|Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas.|
|PMID: 16960149 Owner: NLM Status: MEDLINE|
|Integrative genomic and gene-expression analyses have identified amplified oncogenes in B-cell non-Hodgkin lymphoma (B-NHL), but the capability of such technologies to localize tumor suppressor genes within homozygous deletions remains unexplored. Array-based comparative genomic hybridization (CGH) and gene-expression microarray analysis of 48 cell lines derived from patients with different B-NHLs delineated 20 homozygous deletions at 7 chromosome areas, all of which contained tumor suppressor gene targets. Further investigation revealed that only a fraction of primary biopsies presented inactivation of these genes by point mutation or intragenic deletion, but instead some of them were frequently silenced by epigenetic mechanisms. Notably, the pattern of genetic and epigenetic inactivation differed among B-NHL subtypes. Thus, the P53-inducible PIG7/LITAF was silenced by homozygous deletion in primary mediastinal B-cell lymphoma and by promoter hypermethylation in germinal center lymphoma, the proapoptotic BIM gene presented homozygous deletion in mantle cell lymphoma and promoter hypermethylation in Burkitt lymphoma, the proapoptotic BH3-only NOXA was mutated and preferentially silenced in diffuse large B-cell lymphoma, and INK4c/P18 was silenced by biallelic mutation in mantle-cell lymphoma. Our microarray strategy has identified novel candidate tumor suppressor genes inactivated by genetic and epigenetic mechanisms that substantially vary among the B-NHL subtypes.|
|Cinta Mestre-Escorihuela; Fanny Rubio-Moscardo; Jose A Richter; Reiner Siebert; Joan Climent; Vicente Fresquet; Elena Beltran; Xabier Agirre; Isabel Marugan; Miguel Marín; Andreas Rosenwald; Kei-Ji Sugimoto; Luise M Wheat; E Loraine Karran; Juan F García; Lydia Sanchez; Felipe Prosper; Louis M Staudt; Daniel Pinkel; Martin J S Dyer; Jose A Martinez-Climent|
Related Documents :
|15677569 - Expression of the human germinal center-associated lymphoma (hgal) protein, a new marke...
9207459 - Prognostic significance of bcl-2 protein expression and bcl-2 gene rearrangement in dif...
15876249 - Microarray-based classification of diffuse large b-cell lymphoma.
14759339 - Kaposi's sarcoma-associated herpesvirus (kshv)/human herpesvirus 8 (hhv-8) as a tumour ...
20579129 - Foxp1 protein overexpression is associated with inferior outcome in nodal diffuse large...
14617009 - Frequent aberrant promoter hypermethylation of o6-methylguanine-dna methyltransferase a...
18395839 - Temporally controlled prostate epithelium-specific gene alterations.
16909399 - Schizophrenia and oxidative stress: glutamate cysteine ligase modifier as a susceptibil...
23286399 - Regulatory effects of cyclosporin a and tacrolimus on th immunological gene expressions...
|Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2006-09-07|
|Title: Blood Volume: 109 ISSN: 0006-4971 ISO Abbreviation: Blood Publication Date: 2007 Jan|
|Created Date: 2006-12-27 Completed Date: 2007-02-20 Revised Date: 2014-02-19|
Medline Journal Info:
|Nlm Unique ID: 7603509 Medline TA: Blood Country: United States|
|Languages: eng Pagination: 271-80 Citation Subset: AIM; IM|
|APA/MLA Format Download EndNote Download BibTex|
Apoptosis Regulatory Proteins / genetics*
Carrier Proteins / genetics*
Cell Line, Tumor
Chromosomes, Human / genetics, ultrastructure
Cyclin-Dependent Kinase Inhibitor p18 / genetics*
DNA Mutational Analysis
DNA, Neoplasm / genetics
Gene Expression Regulation, Neoplastic
Genes, Tumor Suppressor*
Homeodomain Proteins / genetics*
Lymphoma, B-Cell / classification, genetics*, immunology, pathology
Membrane Proteins / genetics*
Nuclear Proteins / genetics*
Nucleic Acid Hybridization
Oligonucleotide Array Sequence Analysis
Promoter Regions, Genetic / genetics
Proto-Oncogene Proteins / genetics*
Proto-Oncogene Proteins c-bcl-2 / genetics*
Transcription Factors / genetics*
Vesicular Transport Proteins / genetics*
|MC_U132670597//Medical Research Council|
|0/Apoptosis Regulatory Proteins; 0/Bcl-2-like protein 11; 0/CDKN2C protein, human; 0/Carrier Proteins; 0/Cyclin-Dependent Kinase Inhibitor p18; 0/DNA, Neoplasm; 0/Homeodomain Proteins; 0/LITAF protein, human; 0/Membrane Proteins; 0/Nuclear Proteins; 0/PMAIP1 protein, human; 0/Proto-Oncogene Proteins; 0/Proto-Oncogene Proteins c-bcl-2; 0/SNX25 protein, human; 0/SORBS2 protein, human; 0/Sorting Nexins; 0/Transcription Factors; 0/Vesicular Transport Proteins|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Lenalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase 2 trial.
Next Document: Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with nor...